Cross-sectional evaluation of a clinical decision support tool to identify medication-related problems at discharge from the acute care setting

被引:0
作者
Dicristina, Savanna [1 ,2 ,3 ,4 ]
Turgeon, Jacques [5 ,6 ]
Michaud, Veronique [5 ,6 ,7 ]
Brunetti, Luigi [1 ,2 ]
机构
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Piscataway, NJ USA
[2] Robert Wood Johnson Barnabas Hlth RWJUH Somerset, Somerville, NJ USA
[3] Tabula Rasa HealthCare, Moorestown, NJ USA
[4] Northeastern Univ, Bouve Coll Hlth Sci, Sch Pharm & Pharmaceut Sci, Boston, MA USA
[5] GalenusRx, Orlando, FL USA
[6] Univ Montreal, Fac Pharm, Montreal, PQ, Canada
[7] CHU Montreal, Ctr Rech, CRCHUM, Montreal, PQ, Canada
来源
JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY | 2024年 / 7卷 / 08期
关键词
clinical decision support systems; risk score; safety; ADVERSE DRUG-REACTIONS; PHARMACIST; IMPLEMENTATION; PROGRAM; SCORE; RISK;
D O I
10.1002/jac5.1998
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BackgroundThere are many reported pharmacist-led transitions of care (TOC) programs to address medication-related problems (MRP) at discharge from the acute care setting. Most have identified time and labor resources as significant limitations. This study aims to assess the effectiveness of a medication risk score (MRS)-driven clinical decision support system (CDSS) in identifying actionable MRPs and improving medication safety in the acute care discharge TOC setting.MethodsA cross-sectional analysis was conducted in a cohort of 481 subjects discharged from the acute care setting. The MRS-CDSS was utilized to identify MRPs and provide recommendations for risk reduction. The distribution of MRPs, recommendations, and their associations with MRS severity were analyzed. Additionally, the potential reduction in MRS per subject and its correlation with MRS severity were examined.ResultsThe median MRS reduction per subject was 2 points, while high/severe-risk patients showed a median potential reduction of 7 points. Among the identified MRPs (n = 691), drug interaction, drug use without indication, and adverse drug reaction accounted for 89.7% of all MRPs. The top three recommendations, discontinue medication, change the time of administration, and start alternative therapy, represented 94.1% of all recommendations. Stratified analysis by MRS category revealed a significant increase in adverse drug reaction MRPs and recommendations to discontinue medications with higher MRS severity. The results were consistent with previous outpatient studies, supporting the MRS-CDSS's ability to enhance medication safety.ConclusionThis study demonstrates that the MRS-CDSS effectively identifies actionable MRPs and has the potential to substantially reduce overall pharmacotherapy regimen risk when applied during acute care discharge TOC. The findings support implementable recommendations directed at patient safety and the allocation of health care resources to high-risk patients for maximum benefit.
引用
收藏
页码:763 / 771
页数:9
相关论文
共 34 条
  • [1] Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care
    Ahrens, D.
    Behrens, G.
    Himmel, W.
    Kochen, M. M.
    Chenot, J. -F.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (08) : 767 - 773
  • [2] Bankes D., 2021, AM J MANAG CARE, V27
  • [3] Predicting the rate of physician-accepted interventions by hospital pharmacists in the United Kingdom
    Barber, ND
    Batty, R
    Ridout, DA
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (04) : 397 - 405
  • [4] Anticholinergic and sedative drug burden in community-dwelling older people: a national database study
    Byrne, Catherine J.
    Walsh, Caroline
    Cahir, Caitriona
    Ryan, Cristin
    Williams, David J.
    Bennett, Kathleen
    [J]. BMJ OPEN, 2018, 8 (07):
  • [5] Cicali BM., 2018, BENEFITS Q, P49
  • [6] Cohen J., 1992, CURRENT DIRECTIONS P, V1, P98, DOI [10.1111/1467-8721.ep10768783, DOI 10.1111/1467-8721.EP10768783]
  • [7] Implementation of a proton pump inhibitor stewardship program
    Davis, Kelly W.
    Hanners, Rachel E.
    Lockwood, Sean M.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (12) : 932 - 937
  • [8] Evaluation of Clinical Pharmacist Services in a Transitions of Care Program Provided to Patients at Highest Risk for Readmission
    Fennelly, Jessica E.
    Coe, Antoinette B.
    Kippes, Kellie A.
    Remington, Tami L.
    Choe, Hae Mi
    [J]. JOURNAL OF PHARMACY PRACTICE, 2020, 33 (03) : 314 - 320
  • [9] Drug Burden Index and physical function in older Australian men
    Gnjidic, Danijela
    Cumming, Robert G.
    Le Couteur, David G.
    Handelsman, David J.
    Naganathan, Vasi
    Abernethy, Darrell R.
    Hilmer, Sarah N.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (01) : 97 - 105
  • [10] Gunterus Alicia, 2016, Ment Health Clin, V6, P242, DOI 10.9740/mhc.2016.09.242